Michael Leahy Selected Research

Sarcoma (Soft Tissue Sarcoma)

1/2019	Cediranib in patients with alveolar soft-part sarcoma (CASPS): a double-blind, placebo-controlled, randomised, phase 2 trial.
1/2019	Impact of Concomitant Administration of Gastric Acid-Suppressive Agents and Pazopanib on Outcomes in Soft-Tissue Sarcoma Patients Treated within the EORTC 62043/62072 Trials.
10/2017	Gemcitabine and docetaxel versus doxorubicin as first-line treatment in previously untreated advanced unresectable or metastatic soft-tissue sarcomas (GeDDiS): a randomised controlled phase 3 trial.
7/2014	Phase II study of cediranib in patients with advanced gastrointestinal stromal tumors or soft-tissue sarcoma.
10/2012	Adjuvant chemotherapy with doxorubicin, ifosfamide, and lenograstim for resected soft-tissue sarcoma (EORTC 62931): a multicentre randomised controlled trial.
1/2012	Quality of Life and Utility in Patients with Metastatic Soft Tissue and Bone Sarcoma: The Sarcoma Treatment and Burden of Illness in North America and Europe (SABINE) Study.
1/2007	Brostallicin, an agent with potential activity in metastatic soft tissue sarcoma: a phase II study from the European Organisation for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group.
1/2006	A Phase II Nonrandomised Open-Label Study of Liposomal Daunorubicin (DaunoXome) in Advanced Soft Tissue Sarcoma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Michael Leahy Research Topics

Disease

8	Sarcoma (Soft Tissue Sarcoma) 01/2019 - 01/2006
7	Neoplasms (Cancer) 01/2021 - 01/2007
2	Hypertension (High Blood Pressure) 01/2019 - 01/2013
2	Disease Progression 10/2017 - 01/2013
2	Allergic Rhinitis 07/2005 - 02/2005
1	Vomiting 01/2019
1	Alveolar Soft Part Sarcoma 01/2019
1	Proteinuria 01/2019
1	Dehydration (Water Stress) 01/2019
1	Fever (Fevers) 10/2017
1	Fatigue 10/2017
1	Neutropenia 10/2017
1	Pain (Aches) 10/2017
1	Stomatitis 10/2017
1	Febrile Neutropenia 10/2017
1	Gastrointestinal Stromal Tumors (Gastrointestinal Stromal Tumor) 07/2014
1	Embryonal Carcinoma 04/2010
1	Acquired Immunodeficiency Syndrome (AIDS) 03/2009
1	Hematologic Neoplasms (Hematological Malignancy) 03/2009
1	Delirium 03/2009
1	Sleep Initiation and Maintenance Disorders (Insomnia) 03/2009
1	Idiopathic Thrombocytopenic Purpura (Thrombocytopenic Purpura, Autoimmune) 03/2009
1	Psychotic Disorders (Schizoaffective Disorder) 03/2009
1	Purpura 03/2009
1	Multiple Myeloma 03/2009
1	Mood Disorders (Mood Disorder) 03/2009
1	Lymphoma (Lymphomas) 12/2008
1	Thrombophilia 10/2006
1	Antiphospholipid Syndrome (Antiphospholipid Antibody Syndrome) 10/2006
1	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2005
1	Hemorrhage 12/2003
1	Wounds and Injuries (Trauma) 12/2003

Drug/Important Bio-Agent (IBA)

4	Gemcitabine FDA Link 10/2017 - 12/2008
3	Cisplatin (Platino)FDA LinkGeneric 01/2012 - 11/2009
2	cediranib (AZD2171)IBA 01/2019 - 07/2014
2	Doxorubicin (Adriamycin)FDA LinkGeneric 10/2017 - 10/2012
2	Imatinib Mesylate (Gleevec)FDA Link 07/2014 - 01/2013
2	Ifosfamide FDA LinkGeneric 10/2012 - 12/2008
2	Vinblastine (Vinblastine Sulfate)FDA Link 01/2012 - 11/2009
2	Methotrexate (Mexate)FDA LinkGeneric 01/2012 - 11/2009
2	Carboplatin (JM8)FDA LinkGeneric 01/2012 - 11/2009
2	Adrenal Cortex Hormones (Corticosteroids)IBA 03/2009 - 02/2005
1	pazopanib FDA Link 01/2019
1	Docetaxel (Taxotere)FDA Link 10/2017
1	Deoxyglucose (2 Deoxy D glucose)IBA 07/2014
1	regorafenibIBA 01/2013
1	Sunitinib (Sutent)FDA Link 01/2013
1	LenograstimIBA 10/2012
1	nutlin 3IBA 04/2010
1	Prednisolone (Predate)FDA LinkGeneric 03/2009
1	Dexamethasone (Maxidex)FDA LinkGeneric 03/2009
1	Vinorelbine (Navelbine)FDA LinkGeneric 12/2008
1	brostallicinIBA 01/2007
1	DNA (Deoxyribonucleic Acid)IBA 01/2007
1	Thromboplastin (Tissue Factor)IBA 10/2006
1	AutoantibodiesIBA 10/2006
1	AntibodiesIBA 10/2006
1	Thrombin FDA Link 10/2006
1	lipoprotein-associated coagulation inhibitor (TFPI)IBA 10/2006
1	Immunoglobulin G (IgG)IBA 10/2006
1	Antiphospholipid AntibodiesIBA 10/2006
1	AnthracyclinesIBA 01/2006
1	Daunorubicin (Cerubidine)FDA LinkGeneric 01/2006
1	Histamine Antagonists (Antihistamines)IBA 07/2005
1	Non-Sedating Histamine H1 Antagonists (Histamine H1 Antagonists, Non Sedating)IBA 07/2005
1	Cytarabine (Cytosar-U)FDA LinkGeneric 01/2005

Therapy/Procedure

7	Drug Therapy (Chemotherapy) 01/2019 - 01/2005
4	Therapeutics 01/2021 - 01/2005
1	Radiotherapy 01/2019
1	Adjuvant Chemotherapy 10/2012
1	Ambulatory Care (Outpatient Care) 12/2008
1	Consolidation Chemotherapy 01/2005
1	Orthoptics (Orthoptic) 12/2003
1	Liver Transplantation 12/2003
1	Vascular Surgical Procedures 12/2003